Strontium ranelate

CAS: 135459-87-9

Ref. TM-T1641

Informação sobre produto

• Nome: Strontium ranelate
• Sinónimos: Distrontium renelate, S12911, 3-Thiopheneacetic acid, 5-[bis(carboxymethyl)amino]-2-carboxy-4-cyano-, strontium salt (1:2), 5-[Bis(Carboxymethyl)Amino]-3-(Carboxymethyl)-4-Cyanothiophene-2-Carboxylic Acid, 5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt, 5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt (1:2), Bivalos, Distrontium renelate, Osseor, Protelos, Protos, Ranelate Strontium, S 12911, S 12911-2, Strometta, Stroncium Ranelate, Strontium 5-[Bis(Carboxylatomethyl)Amino]-3-(Carboxylatomethyl)-4-Cyanothiophene-2-Carboxylate Hydrate (2:1:7)
• CAS: 135459-87-9

Descrição

Strontium ranelate (S12911), a strontium (II) salt of the ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in the treatment of severe osteoporosis.

• Marca: Targetmol

Propriedades químicas

• Peso molecular: 513.49
• Fórmula: C₁₂H₆N₂O₈S·2Sr
• Pureza: 100%
• Cor/forma: Crystalline Solid